Medical Marijuana, Inc.
MJNA
Rank in Stocks
#33358
Established in 2005 and based in San Diego, California, Medical Marijuana, Inc.... Established in 2005 and based in San Diego, California, Medical Marijuana, Inc. operates as an investment holding entity primarily focused on the cannabinoid-based health and wellness industry. The company specializes in the development, marketing, and global distribution of hemp oils rich in naturally occurring cannabinoids, including CBD, alongside a variety of other non-psychoactive cannabidiol products. It also innovates with cannabis/cannabinoid-infused chewing gum, specifically formulated for the therapeutic management of pain and various other medical conditions. Beyond its core product offerings, the firm commits significant resources to research and development. This includes exploring novel therapeutic agents designed to mitigate oxidative stress, modulate immune responses, and provide neuroprotection. It also offers a comprehensive range of dietary supplements, skincare solutions, and prescription-grade hemp oils, distributed under its well-known Kannaway and HempMeds brands. Furthermore, Medical Marijuana, Inc. implements proprietary methodologies for testing, genetic selection, labeling, packaging, tracking, production, and standardization across the medicinal cannabinoid sector. Its product portfolio extends to include RSHO oil, addressing diverse health concerns, as well as a line of plant-based, non-GMO pet products that cater to animal health, recreation, and environmentally conscious needs.
Share Price
$0.0001
Last synced: 2026-11-09
Market Cap
$568.95K
Change (1 day)
-50.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Medical Marijuana, Inc. (MJNA)
Category
Healthcare
Operating Margin for Medical Marijuana, Inc. (MJNA)
Operating Margin as of November 2026 TTM: -13.49%
According to Medical Marijuana, Inc.'s latest financial reports, its current operating margin (TTM) is -13.49%. At the end of 2025 the company had an operating margin of -7.27%.
Operating Margin history for Medical Marijuana, Inc. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -13.49% | 85.56% |
| 2025 | -7.27% | 72,600.00% |
| 2024 | -0.01% | -99.96% |
| 2023 | -26.72% | 42.66% |
| 2022 | -18.73% | 259.50% |
| 2021 | -5.21% | 13.76% |
| 2020 | -4.58% | -343.62% |
| 2019 | 1.88% | -111.79% |
| 2018 | -15.95% | 6.69% |
| 2017 | -14.95% | -72.79% |
| 2016 | -54.94% | 17.07% |
| 2015 | -46.93% | 161.74% |
| 2014 | -17.93% | -528.95% |
| 2013 | 4.18% | -93.33% |
| 2012 | 62.64% | -101.59% |
| 2010 | -3,937.42% | 187.36% |
| 2009 | -1,370.22% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -101.44% |
DE
|
|
| 19.68% | -101.46% |
DE
|
|
| 13.26% | -100.98% |
JP
|
|
| 17.08% | -101.27% |
CH
|
|
| 14.92% | -101.11% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Medical Marijuana, Inc.'s operating margin
What is Medical Marijuana, Inc.'s operating margin?
Medical Marijuana, Inc.'s operating margin is -13.49%, as of Nov 2026.
What was Medical Marijuana, Inc.'s operating margin in 2025?
In 2025, Medical Marijuana, Inc.'s operating margin was -7.27%, compared with -0.01% in 2024.
How has Medical Marijuana, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Medical Marijuana, Inc.'s operating margin was highest in 2024 (-0.01%) and lowest in 2023 (-26.72%).
How does Medical Marijuana, Inc.'s operating margin compare with similar companies?
Medical Marijuana, Inc.'s operating margin (-13.49%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.